TTM
$23.26B
YoY change
+5.9%
5Y CAGR
+4.4%
Peak year (2025)
$23.92B
Cumulative EBITDA
$501.29B
EBITDA history chart for Procter & Gamble (PG) from 1986 to 2025
Latest: $23.92B
EBITDA growth chart for Procter & Gamble (PG) from 1986 to 2025
Latest: +5.9%
EBITDA history table for Procter & Gamble (PG) from 1986 to 2025
| 2025 | $23.92B | +5.9% | +$1.34B | ||
| 2024 | $22.58B | +3.7% | +$811.00M | ||
| 2023 | $21.77B | +2.5% | +$530.00M | ||
| 2022 | $21.24B | +1.9% | +$389.00M | ||
| 2021 | $20.85B | +8.0% | +$1.54B | ||
| 2020 | $19.31B | +105.4% | +$9.91B | ||
| 2019 | $9.40B | -43.6% | −$7.26B | ||
| 2018 | $16.67B | +0.7% | +$124.00M | ||
| 2017 | $16.54B | -2.2% | −$379.00M | ||
| 2016 | $16.92B | +15.5% | +$2.27B | ||
| 2015 | $14.65B | -15.6% | −$2.71B | ||
| 2014 | $17.36B | -2.6% | −$469.00M | ||
| 2013 | $17.83B | +8.0% | +$1.33B | ||
| 2012 | $16.50B | -11.6% | −$2.17B | ||
| 2011 | $18.67B | -1.4% | −$256.00M | ||
| 2010 | $18.92B | +0.7% | +$125.00M | ||
| 2009 | $18.80B | -7.2% | −$1.47B | ||
| 2008 | $20.27B | +9.1% | +$1.69B | ||
| 2007 | $18.58B | +17.0% | +$2.70B | ||
| 2006 | $15.88B | +28.5% | +$3.52B | ||
| 2005 | $12.35B | +11.1% | +$1.24B | ||
| 2004 | $11.12B | +16.3% | +$1.56B | ||
| 2003 | $9.56B | +14.2% | +$1.19B | ||
| 2002 | $8.37B | +19.5% | +$1.36B | ||
| 2001 | $7.01B | -14.0% | −$1.14B | ||
| 2000 | $8.14B | -3.0% | −$256.00M | ||
| 1999 | $8.40B | +9.8% | +$748.00M | ||
| 1998 | $7.65B | +9.7% | +$678.00M | ||
| 1997 | $6.97B | +13.0% | +$802.00M | ||
| 1996 | $6.17B | +12.3% | +$676.00M | ||
| 1995 | $5.50B | +16.6% | +$783.00M | ||
| 1994 | $4.71B | +195.4% | +$3.12B | ||
| 1993 | $1.60B | -59.3% | −$2.32B | ||
| 1992 | $3.92B | +7.1% | +$260.00M | ||
| 1991 | $3.66B | +15.7% | +$497.00M | ||
| 1990 | $3.16B | +12.7% | +$355.00M | ||
| 1989 | $2.81B | +12.6% | +$313.00M | ||
| 1988 | $2.49B | +73.6% | +$1.06B | ||
| 1987 | $1.44B | -20.0% | −$360.00M | ||
| 1986 | $1.80B | — | — |
- 2025$23.92B+5.9%
- 2024$22.58B+3.7%
- 2023$21.77B+2.5%
- 2022$21.24B+1.9%
- 2021$20.85B+8.0%
- 2020$19.31B+105.4%
- 2019$9.40B-43.6%
- 2018$16.67B+0.7%
- 2017$16.54B-2.2%
- 2016$16.92B+15.5%
- 2015$14.65B-15.6%
- 2014$17.36B-2.6%
- 2013$17.83B+8.0%
- 2012$16.50B-11.6%
- 2011$18.67B-1.4%
- 2010$18.92B+0.7%
- 2009$18.80B-7.2%
- 2008$20.27B+9.1%
- 2007$18.58B+17.0%
- 2006$15.88B+28.5%
- 2005$12.35B+11.1%
- 2004$11.12B+16.3%
- 2003$9.56B+14.2%
- 2002$8.37B+19.5%
- 2001$7.01B-14.0%
- 2000$8.14B-3.0%
- 1999$8.40B+9.8%
- 1998$7.65B+9.7%
- 1997$6.97B+13.0%
- 1996$6.17B+12.3%
- 1995$5.50B+16.6%
- 1994$4.71B+195.4%
- 1993$1.60B-59.3%
- 1992$3.92B+7.1%
- 1991$3.66B+15.7%
- 1990$3.16B+12.7%
- 1989$2.81B+12.6%
- 1988$2.49B+73.6%
- 1987$1.44B-20.0%
- 1986$1.80B—
EBITDA values are taken from Procter & Gamble's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Procter & Gamble (PG)
According to Procter & Gamble's latest reported financial statements, the company's current EBITDA (TTM) is $23.26B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Procter & Gamble (PG) reported EBITDA of $23.92B – grew 5.9% year-over-year.
Through 2020–2025 (5 years), Procter & Gamble EBITDA delivered a +4.4% annualised rate; sustaining 6 straight years of year-over-year growth.
The record annual EBITDA stands at $23.92B, reached in 2025; the historical low of $1.44B was recorded in 1987.
Procter & Gamble EBITDA by Year
Procter & Gamble EBITDA 2025: $23.92B
In 2025, Procter & Gamble reported EBITDA of $23.92B, grew 5.9% from 2024. This figure represents the highest annual value in the available history.
Procter & Gamble EBITDA 2024: $22.58B
Procter & Gamble EBITDA in 2024 was $22.58B, edged up 3.7% from 2023.
Procter & Gamble EBITDA 2023: $21.77B
2023's EBITDA for Procter & Gamble came in at $21.77B, edged up 2.5% from 2022.
Procter & Gamble EBITDA 2022: $21.24B
Procter & Gamble posted EBITDA of $21.24B in 2022, edged up 1.9% from 2021.
Procter & Gamble EBITDA 2021: $20.85B
Procter & Gamble EBITDA in 2021 was $20.85B.
See more financial history for Procter & Gamble (PG).
Sector peers by EBITDA
Consumer Defensive peers of Procter & Gamble (PG), ranked by their latest EBITDA
| $46.47B | |
| $18.70B | |
| $17.46B | |
| $15.54B | |
| $13.40B | |
| $10.83B | |
| $4.65B | |
| $2.60B |
- $46.47B
- $18.70B
- $15.54B
- $13.40B
- $10.83B
- $2.60B
Frequently asked questions
Procter & Gamble (PG) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation